SEARCH RESULT

Total Matching Records found : 3172

Aadhaar–LPG linkage still tardy in Andhra Pradesh

-The Hindu ‘consumers must get Aadhaar number linked todatabase of oil companies and bank accounts' Hyderabad: Even as the Centre announced that the rollout of direct transfer of the cash subsidy on LPG would be from June 1, only 55 per cent of consumers got their Aadhaar number linked to the database of oil companies in the five districts in Andhra Pradesh. Even poorer is the linkage of Aadhaar numbers to the bank...

More »

Reforms’ unintended fallout -Ashoak Upadhyay

-The Hindu Business Line A mint-fresh working paper by the Reserve Bank of India once again trains the spotlight on a problem that, for five decades, every policy-maker has planned to snuff out, failed to, and then wished it would go away if ignored. But financial exclusion simply hasn't, and we now have the central bank applying its forensic skills to an examination of its magnitude. The title of Working Paper Series...

More »

Age of graft -CP Chandrasekhar

-Frontline Corruption tends to be greater in periods when there is a state-engineered redistribution of wealth in favour of a few at the explicit or implicit expense of the many. Liberalisation is one such period. IT cannot be verified and may not be true. But, the view that the record of graft and corruption during the two-term, nine-year rule of the United Progressive Alliance (UPA) is the worst in India's post-Independence...

More »

India’s premier sexist league-Sharda Ugra

-The HIndu For all its influential reach, the IPL has done little to combat the existing stereotypes about women and done everything to reinforce them IPL 2013 is heading towards its high-intensity, high-octane, high-pitched finale. After the season's numbers have been crunched, the League will dissipate into general back-slapping, errors and omissions excepted. Except that 2013 has been a revelation in itself. While the IPL occupies "soap opera" prime time on TV for...

More »

Ranbaxy fined $500 m for flawed generics-Narayan Lakshman

-The Hindu Ranbaxy, one of India's largest pharmaceutical companies, has agreed to pay $500 million fines levied by U.S. authorities for selling adulterated drugs and lying to federal regulators in a case that is part of an ongoing crackdown on the quality of generic drugs flowing into the U.S. The deal struck on Monday, said to be the largest financial penalty against a generic drug company for violations of FDA standards, came...

More »

Video Archives

Archives

share on Facebook
Twitter
RSS
Feedback
Read Later

Contact Form

Please enter security code
      Close